{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:44:51Z","timestamp":1760298291091},"reference-count":36,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2007,7,29]],"date-time":"2007-07-29T00:00:00Z","timestamp":1185667200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Oral Pathology Medicine"],"published-print":{"date-parts":[[2008,3]]},"abstract":"<jats:p><jats:bold>Objectives:\u2002<\/jats:bold> Over\u2010expression of the proto\u2010oncogene c\u2010erbB\u20102 (HER\u20102\/<jats:italic>neu<\/jats:italic>) has been shown to be a prognostic marker in many kinds of cancer, whereas conflicting data exist about the prevalence of HER\u20102\/<jats:italic>neu<\/jats:italic> over\u2010expression in squamous cell carcinoma (SCC) of the tongue. The status of Her\u20102\/<jats:italic>neu<\/jats:italic> was evaluated in a series of SCC of the tongue to verify the frequency of over\u2010expression of HER\u20102\/neu and evaluate the correlation with traditional diagnostic parameters of this neoplasm.<\/jats:p><jats:p><jats:bold>Method:\u2002<\/jats:bold> Fourty patients with SCC of the tongue were investigated for over\u2010expression of the protein through immunohistochemistry using CB11 antibody, the Hercep Test<jats:sup>\u00ae<\/jats:sup> kit and FISH.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Data obtained using the Hercep Test<jats:sup>\u00ae<\/jats:sup> differ from published reports concerning the over\u2010expression of Her\u20102\/<jats:italic>neu<\/jats:italic> and there was no correlation between levels of expression of Her\u20102\/<jats:italic>neu<\/jats:italic> and other clinico\u2010pathological and\/or prognostic parameters. Of the 40 specimens, using CB11 we obtained results in line with published reports; however, with the Hercep Test<jats:sup>\u00ae<\/jats:sup> we found only 1 positive case (2.5%) (score 3+).<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> These data, confirmed by FISH, suggest that Her\u20102\/<jats:italic>neu<\/jats:italic> is not a suitable marker that could play a primary role in the clinical\u2010therapeutic management of SCC of the tongue.<\/jats:p>","DOI":"10.1111\/j.1600-0714.2007.00603.x","type":"journal-article","created":{"date-parts":[[2010,8,12]],"date-time":"2010-08-12T12:09:06Z","timestamp":1281614946000},"page":"145-150","source":"Crossref","is-referenced-by-count":15,"title":["Comparative analysis of c\u2010erbB\u20102 (HER\u20102\/<i>neu<\/i>) in squamous cell carcinoma of the tongue: does over\u2010expression exist? And what is its correlation with traditional diagnostic parameters?"],"prefix":"10.1111","volume":"37","author":[{"given":"Francesca","family":"Angiero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachele Del","family":"Sordo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Dessy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angiola","family":"Berenzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Stefani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Sidoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,2,3]]},"reference":[{"doi-asserted-by":"publisher","key":"e_1_2_5_2_2","DOI":"10.1054\/bjoc.2000.1323"},{"doi-asserted-by":"publisher","key":"e_1_2_5_3_2","DOI":"10.3322\/canjclin.49.1.8"},{"doi-asserted-by":"publisher","key":"e_1_2_5_4_2","DOI":"10.1200\/JCO.2000.18.10.2046"},{"doi-asserted-by":"publisher","key":"e_1_2_5_5_2","DOI":"10.1093\/jnci\/90.11.824"},{"doi-asserted-by":"publisher","key":"e_1_2_5_6_2","DOI":"10.1177\/000348949610500406"},{"doi-asserted-by":"publisher","key":"e_1_2_5_7_2","DOI":"10.1111\/j.1600-0714.1999.tb02103.x"},{"doi-asserted-by":"publisher","key":"e_1_2_5_8_2","DOI":"10.1126\/science.2470152"},{"doi-asserted-by":"publisher","key":"e_1_2_5_9_2","DOI":"10.1001\/archotol.1995.01890110041008"},{"doi-asserted-by":"publisher","key":"e_1_2_5_10_2","DOI":"10.1016\/0304-3835(92)90234-M"},{"key":"e_1_2_5_11_2","first-page":"5675","article-title":"Amplification and overexpression of HER\u20102\/neu in carcinomas of the salivary gland: correlation with poor prognosis","volume":"4","author":"Press MF","year":"1994","journal-title":"Cancer Res"},{"key":"e_1_2_5_12_2","first-page":"3","article-title":"Strong correlation between c\u2010erbB\u20102 overexpression and overall survival of patients with oral squamous cell carcinoma","volume":"3","author":"Xia W","year":"1997","journal-title":"Clin Cancer Res"},{"key":"e_1_2_5_13_2","first-page":"540","article-title":"Characterization of the HER\u20102\/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma","volume":"8","author":"Khan AJ","year":"2002","journal-title":"Clin Cancer Res"},{"doi-asserted-by":"publisher","key":"e_1_2_5_14_2","DOI":"10.1016\/S1368-8375(02)00029-5"},{"doi-asserted-by":"publisher","key":"e_1_2_5_15_2","DOI":"10.1016\/j.oraloncology.2003.11.004"},{"doi-asserted-by":"publisher","key":"e_1_2_5_16_2","DOI":"10.1016\/S0304-3835(02)00265-3"},{"year":"1992","author":"American Joint Committee on Cancer","journal-title":"Manual for staging cancer","key":"e_1_2_5_17_2"},{"key":"e_1_2_5_18_2","first-page":"2333","article-title":"Detection of HER\u20102\/neu (c\u2010erbB\u20102) overexpression and amplification in breast carcinomas with ambiguous immunohistochemical results. A further contribution to defining the role of fluorescent in situ hybridization","volume":"26","author":"Sidoni A","year":"2006","journal-title":"Anticancer Res"},{"doi-asserted-by":"publisher","key":"e_1_2_5_19_2","DOI":"10.1093\/jnci\/90.13.1000"},{"doi-asserted-by":"publisher","key":"e_1_2_5_20_2","DOI":"10.1309\/6ANB-QXCF-EHKC-7UC7"},{"doi-asserted-by":"publisher","key":"e_1_2_5_21_2","DOI":"10.1136\/jcp.53.12.890"},{"doi-asserted-by":"publisher","key":"e_1_2_5_22_2","DOI":"10.1136\/jcp.2003.007724"},{"doi-asserted-by":"publisher","key":"e_1_2_5_23_2","DOI":"10.1111\/j.1600-0714.1990.tb00869.x"},{"key":"e_1_2_5_24_2","first-page":"613","article-title":"c\u2010erbB\u20102 expression in squamous cell carcinoma of the head and neck","volume":"12","author":"Field JK","year":"1992","journal-title":"Anticancer Res"},{"key":"e_1_2_5_25_2","first-page":"2273","article-title":"Expression of c\u2010erbB\u20102 gene in human head and neck carcinoma","volume":"12","author":"Craven JM","year":"1992","journal-title":"Anticancer Res"},{"key":"e_1_2_5_26_2","first-page":"4539","article-title":"Expression of c\u2010erbB proto\u2010oncogene family members in squamous cell carcinoma of the head and neck","volume":"17","author":"Ibrahim SO","year":"1997","journal-title":"Anticancer Res"},{"key":"e_1_2_5_27_2","first-page":"4164","article-title":"Combination of EGFR, HER\u20102\/neu, and HER\u20103 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members","volume":"5","author":"Xia W","year":"1999","journal-title":"Clin Cancer Res"},{"doi-asserted-by":"publisher","key":"e_1_2_5_28_2","DOI":"10.1016\/S0304-3835(02)00242-2"},{"doi-asserted-by":"publisher","key":"e_1_2_5_29_2","DOI":"10.1111\/j.0959-9673.2004.00361.x"},{"key":"e_1_2_5_30_2","first-page":"1177","article-title":"Expression of EGFR, HER2, HER3, and HER4 in metastatic squamous cell carcinomas of the oral cavity and base of tongue","volume":"26","author":"Ekberg T","year":"2005","journal-title":"Int J Oncol"},{"doi-asserted-by":"publisher","key":"e_1_2_5_31_2","DOI":"10.1093\/jnci\/94.11.852"},{"doi-asserted-by":"publisher","key":"e_1_2_5_32_2","DOI":"10.1016\/0006-2952(94)90444-8"},{"doi-asserted-by":"publisher","key":"e_1_2_5_33_2","DOI":"10.1002\/ijc.2910440604"},{"doi-asserted-by":"publisher","key":"e_1_2_5_34_2","DOI":"10.1002\/ijc.2910450112"},{"doi-asserted-by":"publisher","key":"e_1_2_5_35_2","DOI":"10.1309\/0F58-0GRX-FK4R-A6VA"},{"key":"e_1_2_5_36_2","first-page":"2771","article-title":"Sensitivity of HER\u20102\/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression","volume":"54","author":"Press MF","year":"1994","journal-title":"Cancer Res"},{"doi-asserted-by":"publisher","key":"e_1_2_5_37_2","DOI":"10.1159\/000077229"}],"container-title":["Journal of Oral Pathology &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0714.2007.00603.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0714.2007.00603.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T15:00:47Z","timestamp":1697036447000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0714.2007.00603.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["10.1111\/j.1600-0714.2007.00603.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0714.2007.00603.x","archive":["Portico"],"relation":{},"ISSN":["0904-2512","1600-0714"],"issn-type":[{"type":"print","value":"0904-2512"},{"type":"electronic","value":"1600-0714"}],"subject":[],"published":{"date-parts":[[2008,2,3]]}}}